These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 12154405)

  • 41. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia.
    Kumagai T; Tefferi A; Jones L; Koeffler HP
    Leuk Res; 2005 May; 29(5):511-5. PubMed ID: 15755503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of DNA methylation markers for diagnosing cancer.
    Qureshi SA; Bashir MU; Yaqinuddin A
    Int J Surg; 2010; 8(3):194-8. PubMed ID: 20139036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
    van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
    Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
    Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
    Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant DNA methylation as a cancer-inducing mechanism.
    Esteller M
    Annu Rev Pharmacol Toxicol; 2005; 45():629-56. PubMed ID: 15822191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells.
    Jacinto FV; Ballestar E; Ropero S; Esteller M
    Cancer Res; 2007 Dec; 67(24):11481-6. PubMed ID: 18089774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.
    Kang GH; Lee HJ; Hwang KS; Lee S; Kim JH; Kim JS
    Am J Pathol; 2003 Oct; 163(4):1551-6. PubMed ID: 14507661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomas.
    Xiong Z; Wu AH; Bender CM; Tsao JL; Blake C; Shibata D; Jones PA; Yu MC; Ross RK; Laird PW
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):799-803. PubMed ID: 11440966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypermethylation of tumor suppressor genes in cancer.
    Herman JG
    Semin Cancer Biol; 1999 Oct; 9(5):359-67. PubMed ID: 10547344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
    Matsubara N
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
    Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
    Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
    Smiraglia DJ; Plass C
    Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
    Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
    Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.
    Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H
    Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
    Dhillon VS; Shahid M; Husain SA
    Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.